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Abstract 
Due to selective pressure conferred by traditional antibiotic treatment, incidence of 
pathogenic antibiotic resistance continues to present as increasing problem. Many flavonoids 
have been found to have antibacterial effects and synergy between flavonoids, and between 
flavonoids and antibiotics have been found for some combinations. The flavonoids Quercetin, 
Morin, Naringenin and Dihydrokaempferol were tested for activity against the bacterial 
strains S. aureus ATCC 29213 and E.coli ATCC 25922. Using the spot-on method, MIC 
values for Quercetin, Morin and Naringenin were established against E. coli at 2, 4.5 and 3 
mg/mL respectively and at 2.5, 10 and 10 mg/mL respectively against S. aureus. No 
inhibition was shown for either strain with Dihydrokaempferol for concentrations up to 
7.5mg/mL. Combinatorial tests were performed for both strains using Quercetin plus Morin, 
Quercetin plus Naringenin and Morin plus Naringenin. FIC index (FICI) values were 
calculated in order to determine synergistic, additive or antagonistic effects of the different 
combinations. Strong synergism (FICI < 0.6) was found for all combinations against E. coli 
and mild synergism was found against S. aureus for Naringenin plus Morin (FICI = 0.7). 
Possible additive effects were found for other combinations against S. aureus, though more 
testing may further elucidate combinatorial effects for these. Results indicate that due to 
synergistic effects there could be potential for using combination of flavonoids to manage 
E.coli infections and possibly limit the usage of antibiotics, and subsequently the incidence of 
antibiotic resistance.  
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List of abbreviations 
DMSO  Dimethyl Sulfoxide 
CFU  Cell Forming Units 
FIC  Fractional inhibitory concentration 
HPLC  High-performance liquid chromatography  
LB  Lysogeny Broth 
MBC  Minimum Bactericidal Concentration 
MDR  Multiple Drug Resistance  
MHB  Mueller Hinton Broth 
MIC  Minimal inhibitory concentration  
NAG  N-acetylglucosamine  
NAM  N-acetylmuramic acid 
OD  Optical density 
ON  Overnight  
PBP  Penicillin binding proteins  
Rpm  Rounds per minute 
Wt  Wild type 
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Introduction 
Certain strains of the bacterial species Escherichia coli and Staphylococcus aureus, 
classified as Gram-negative and Gram-positive respectively, have acquired resistance to first 
and second-generation antibiotics over the last few decades. This has lead researchers to 
investigate novel methods of antimicrobial treatment as possible replacements for traditional 
antibiotics. Among the candidates for novel treatments are flavonoid compounds. Flavonoids 
are secondary metabolites that play a diverse array of functional roles in plants like grapefruit 
and tomato including petal pigmentation, UV protection and chemical messaging. Many 
different flavonoid compounds have been isolated from a range of plant species and organs 
including fruit, vegetables, nuts, flowers and stems, and other extracts like propolis [1]. The 
potential for antimicrobial effects of certain flavonoids on bacterial species affecting the 
human host is a burgeoning field with further scope for antioxidant, antifungal, anti-tumour 
and anti-hyperglycemic treatment [2] [3]. For this report, we chose to evaluate the 
antimicrobial properties of four flavonoids, namely, Quercetin, Naringenin, Morin and 
Dihydrokaempferol on E. coli and S. aureus. 
 Recent studies exploring the antimicrobial effects of flavonoids have also been 
successful in quantifying inhibition concentrations and to some degree elucidating the 
mechanisms of antimicrobial activity of flavonoids extracted from various sources [4]. 
Research in the field of antimicrobial potential of flavonoids, when applied individually and 
in combinations with other flavonoids or antibiotics for treatment, has shown progress. Lee et 
al. reported strains of bovine isolated methicillin-resistant S. aureus (MRSA) to be 
susceptible to Quercetin and Naringenin [5], and other studies have also reported MRSA to 
be susceptible to Morin [6]. The effects of flavonoid derivatives such as Quercetin-5’-
sulfonic acid and the sodium salt of Morin-5’-sulfonic acid have been shown to have an 
antimicrobial effect on extended-spectrum beta-lactamase producing (ESBL) E. coli strains 
[7].  
Some studies have also been able to show that combining flavonoids with a wide 
variety of antibiotics, to which bacteria are gaining resistance, lower MIC values for both the 
flavonoids and the antibiotic compound when used on MRSA [6] [8]. This warrants attention 
for further study regarding the possible synergisms between flavonoids and between 
flavonoids and antibiotics.  
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S. aureus nasal carriage is a major risk factor for S. aureus infection [9]. This is 
supported by the fact that the nasal S. aureus strain and the infection strain share the same 
genotype [10]. Although the prevalence of MRSA is still very low in Northern European 
countries, there is an increasing incidence of infections worldwide [10]. Currently, 
vancomycin is the only option left for treating MRSA infection, which is major a cause of 
concern as a vancomycin-resistant MRSA (VRSA) strain has recently been isolated in the 
United States [10]. 
            If flavonoids can be shown as effective antimicrobial agents at low concentrations, 
they could be possible novel treatment candidates for preemptive treatment of S. aureus in 
nasal carriers due to their low toxicity.  
 For this report we chose to evaluate the antimicrobial properties of four flavonoids, 
namely, Quercetin, naringenin, Morin and Dihydrokaempferol on E. coli and S. aureus. The 
main aim of the experiment was to carry out susceptibility testing assays to determine the 
MIC values for all four individual flavonoids and combinatorial effects (synergism, 
antagonism or addition) of Quercetin plus Morin, Quercetin plus Naringenin and Naringenin 
plus Morin. The spot-on test method was used in order to determine and quantify MIC values 
and the subsequently derived FIC index (FICI) values which qualify synergism, addition and 
antagonism.   
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Problem formulation 
Can certain flavonoids have antibacterial effects on Gram-positive and Gram-negative 
bacteria, and can they act synergistically when combined? 
Research questions 
• What are the MICs of Morin, Naringenin, Quercetin and Dihydrokaempferol on S. 
aureus ATTC 25923 and E. coli ATCC 25922? 
• Are the combinatorial effects of Morin plus Quercetin, Morin plus Naringenin and 
Quercetin plus Naringenin additive, synergistic or antagonistic on S. aureus ATTC 
25923 and E. coli ATCC 25922?  
Delimitation of project 
Ideally, we would have preferred to explore the effects of our chosen flavonoids on 
antibiotic resistant bacteria, but were limited in doing so by the status of the laboratories we 
have access to. Additionally, due to time constraints we did not extract the respective 
flavonoids from plants-sources ourselves, but ordered them from external sources. 
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Flavonoids 
Flavonoids are a group of compounds typically produced by plants through the 
phenylpropanoid pathway, involving transformation of the amino acid phenylalanine [11]. 
These secondary metabolites have significant functions within the plant such as pigmentation 
for petal coloration, as chemical messengers and UV protectants [2]. Petal coloration plays an 
important role in the attraction of pollinators to flowering plants and hence plant 
reproduction. Furthermore other properties like protecting the plant from foreign microbial 
invasion, cell cycle inhibition and physiological regulation have also been elucidated [12]. In 
addition to antimicrobial activity against plant pathogens enzyme inhibition is also part of the 
regular function of flavonoids [4]. Considered secondary metabolites, i.e. they have no 
known influence on the growth or development of the plant, some research has suggested that 
flavonoids, such as Naringenin, play a role in the inhibition of germination [13].  
Since flavonoids are primarily found in plants, it makes them easily available for 
extraction. There is potential for experimentation and usage in vivo due to their low toxicity 
at effectual concentrations [14].  Flavonoids have been known of since the 1940’s, yet it is 
only in the last 25 years that the importance of the antimicrobial effect in the light of human 
medicinal use has been investigated [4]. The potential of flavonoids as antimicrobial agents 
for human pathogens, especially MRSA strains of bacteria, has gained major headway 
recently. Other beneficial uses for humans include their use as antioxidants, anti-
inflammatory agents, antifungals and even as chemo-preventive agents [2] [15]. Some 
flavonoids have shown antihyperglycemic properties in the murine model, creating room for 
further research in the field [3]. 
 Flavonoids can be categorized in different groups depending on their chemical 
constituents. Some of the major subgroups of flavonoids are: chalcones, aurones, flavones, 
flavonols, isoflavonoids, flavandiols and anthocyanins [16]. The basic structure of a 
flavonoid is depicted in Figure 1. It consists of two benzene rings (A+B) linked together with 
a heterocyclic pyrane ring (C) [4]. The differences between the four flavonoids used for our 
report, in comparison to the basic structure of a flavonoid are shown in Table 1. 
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Figure 1. Flavonoid basic structure [4] 
 
Compound Substituents at carbon position 
 2 3 4 5 6 7 8 2’ 3’ 4’ 5’ 6’ 
Quercetin - OH - OH - OH - - OH OH - - 
Morin - OH - - - OH - OH - OH OH - 
Naringenin - - - OH - OH - - - OH - - 
Dihydrokaempferol - OH - OH -  OH -  - - OH - - 
Table 1. Shows at which carbon-positions the basic flavonoid structure (Figure 1) is hydroxylated [4] 
 
Figure 2. Quercetin [17] 
Quercetin is one of the more extensively studied flavonoids, and is naturally 
abundant. It is typically found in food and plants such as red wine, onions, green tea, apples, 
berries and propolis [18]. Studies have shown that Quercetin has antimicrobial and antiviral 
activity (against 11 viruses), antidiabetic activity and anti-mutagenic activity [19]. Some 
studies have shown that Quercetin has very effective antimicrobial activity against S. aureus 
compared to other flavonoids. The only difference between Quercetin and Morin is one 
hydroxyl group, which can indicate that the placement and that one hydroxyl group can be 
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important for the antimicrobial activity [7]. The bioavailability of Quercetin is disadvantaged 
by oxidative degradation and solubility [18].  
 
Figure 3. Morin hydrate [20] 
Morin (in our case used in the form of Morin hydrate) is a flavonoid found in fruits, 
vegetables and herbs [21]. Morin has been reported to possess antimicrobial properties, and 
has shown beneficial pharmacology for cardiovascular disease, diabetes mellitus, 
neurodegenerative disease, cancer and anti-inflammatory activities [21].  
Figure 4. Naringenin [22] 
Naringenin is the predominant flavonoid in grapefruit and gives it its bitter flavour 
[14]. It is also found in the skin of tomatoes and in oranges [23], and has shown to have 
antioxidant and anti-inflammatory effects [24]. In one study Naringenin has 
antihyperglycemic effects in experimental models on mice with artificially induced diabetes, 
in a comparative range to that produced by anti-diabetic drugs [3].  
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Figure 5. Dihydrokaempferol [25] 
Dihydrokaempferol is typically found in wood, especially in the stem bark of the plant 
Commiphora pedunculata [26]. It is also found in the plant Eucalyptus hemiphloia [27]. A 
few studies that have tested Dihydrokaempferol have shown an antimicrobial effect on S. 
aureus [28].  
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Staphylococcus aureus and Escherichia coli 
Bacterial physiology 
Morphology 
Bacteria are prokaryotic single celled organisms with a rather simple cellular 
organization compared to eukaryotic cells. Unlike eukaryotic cells, most bacteria possess no 
membrane-bound organelles and hence no nucleus [29]. The chromosome is localized in the 
cytoplasm area as a nucleoid or as small circular DNA pieces called plasmids. Also different 
from eukaryotes some bacteria have pili and/or flagella to help them attach to surfaces and 
enhance their motility [29].   
Bacteria vary greatly in size and shape. The two most observed cell shapes are rods 
and cocci (singular, coccus). E. coli is an example of the elongated rod-shaped bacteria, while 
S. aureus is representative of the roughly spherical cocci-shape [29].  
The bacterial cell wall 
Bacteria can be divided into Gram-positive and Gram-negative according to their cell 
envelope structure. The cell envelope is defined as the plasma membrane and any layer 
external to it [29]. For many bacteria that includes a cell wall and at least one additional layer 
of capsule or slime.  
The cell wall protects the cell from osmotic stress and prevents the plasma membrane 
from lysing. In a typical Gram-positive bacterium such as S. aureus, it consists of a single 
homogeneous layer of peptidoglycan outside of the plasma membrane [29]. In contrast the 
typical cell wall of a Gram-negative bacterium such as E. coli, is more complex. It consists of 
two layers: A 10 times thinner peptidoglycan-layer and an outer membrane, both separated 
from the plasma membrane by the periplasmic space [29]. The two are shown and illustrated 
in Figure 6. 
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Figure 6. Cell walls of E. coli and S. aureus [29]. 
The peptidoglycan layer is formed by identical subunits, each with several amino 
acids and two different sugar derivatives N-acetylglucosamine (NAG) and N-acetylmuramic 
acid (NAM) as shown on Figure 7. By linking the sugars, a helical peptidoglycan strand is 
formed with a backbone of peptide side chains pointing in different directions. These side 
chains are then again able to either cross-link, which is typical for E. coli and other Gram-
positive bacteria, or form peptide interbridges, which is typical for S. aureus and other Gram-
negative bacteria [29]. Cross-links form for instance when the carboxyl group of the D-
alanine at position 4 links with the amino group of the diaminopimelic acid at position 3 of 
the other strand.  
Figure 7. NAG and NAM linking in the 
 peptidoglycan layer [29]. 
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Current issues regarding drug resistant strains of E.coli and S. aureus 
Staphylococcus aureus 
Staphylococcus aureus is a very common but sometimes deadly bacterium, once it acquires a 
few antibiotic-resistance genes. In 1948, S. aureus was reported to be resistant against 
penicillin [10]. Not long after, in 1968, the huge outbreak of methicillin resistant S. aureus 
was reported in Boston hospital. This strain was named MRSA (Methicillin-resistant S. 
aureus). Although nowadays the prevalence of MRSA is still very low in northern European 
countries, there is a worldwide increase in number of infections caused by MRSA [10]. 
MRSA infections were treated with vancomycin (“drug of last resort” [29]) until summer 
2002 when the “superbug”, also resistant to vancomycin, arrived. This strain was isolated 
from the foot ulcers of a diabetic patient in Detroit, Michigan, USA, and from this point, it 
became known as the bane of hospitals [29]. This new vancomycin-resistant S. aureus 
(VRSA) is also resistant to many other antibiotics including ciprofloxacin, methicillin and 
penicillin [29]. Generally, MRSA/VRSA is now perceived as non-treatable by an antibiotic 
therapy, which is a major cause for concern. Therefore, the prevention of staphylococcal 
infections and reduction of spread and emergence of MRSA are essential [10]. 
Nasal carriage of S. aureus 
S. aureus colonizes the skin and mucosa of human beings and several other animal 
species. Although many sites in the human body are colonized, the anterior nares of the nose 
are the most frequent carriage of S. aureus [10]. The first association between nasal carriage 
of S. aureus and disease caused by this bacterium was reported in 1931 by Danbolt, who 
studied furunculosis [10]. It is now found that carriage of S. aureus in the nose appears to 
play a key role in the epidemiology and pathogenesis of infection [30]. Three human nasal S. 
aureus carriage patterns can be distinguished: persistent carriage, intermittent carriage and 
non-carriage [9].  
There are many ways in which S. aureus reaches the human nose. Hands are the most 
common vector for transmission, but direct transmission from air is also possible [10]. The 
contact with S. aureus alone is however not enough to become a carrier. After transmission 
by, e.g. nose picking, the S. aureus needs to adhere to the certain receptors in the nares. 
Afterwards, the bacterium also has to overcome the host defences and finally, be able to 
propagate in the nose [10].  
15/74 
 
Density of bacterium in anterior nares is higher in persistent carriers, which may 
partly explain their increased risk for S. aureus infections [9], though it also seems like it has 
a protective effect against the acquisition of other strains during the hospitalization [30]. The 
underlying mechanisms of becoming a nasal carrier are unknown [30].  
Escherichia coli 
Escherichia coli is normally present in the human gut as part of a healthy colony of 
commensal microflora, necessary for digestion and in the case of E. coli, provision of vitamin 
K. Some strains of E.coli have been known to cause food poisoning and urinary tract 
infections in the human host, whereas resistant strains of infective E. coli began appearing in 
outpatient isolates in the early 90s. Since then, some deadly strains of E.coli have been 
responsible for patient deaths all over the world [31].  
Drug resistance in E. coli and S. aureus 
Bacteria gain resistance through horizontal gene transfer of resistant genes like 
resistance plasmids. Both Gram-positive and Gram-negative bacteria employ several 
strategies to protect themselves from the effect of antibiotics once they have gained 
resistance. More than one strategy may also be used in collusion to achieve protection from 
the drug(s) in question, such as: 
Restriction of antibiotic from its target 
One category of protection from antibiotics is modifications that allow bacteria from 
preventing the antibiotic from reaching its target. For example, some bacteria (Gram-
negative) have proteins in their outer peptidoglycan membranes that prevent antibiotics from 
diffusing across. Such porins prevent bulky antibiotics from reaching their cellular targets in 
microbial cells, and bacteria, under selective pressure from antibiotics, can code for a higher 
number of these porins to further reduce their uptake [32]. This is usually coupled with the 
rapid removal of the antibiotic with the use efflux pumps in the cytoplasmic membrane. Both 
E. coli and S. aureus naturally contain varying types of efflux pumps within their cell 
membranes. These pumps are coded for regardless of antibiotic exposure and are involved in 
removing harmful compounds from within the cell [33]. Efflux pumps are protein channels 
formed within the cell membrane(s) of bacteria which have the ability to pump out noxious 
materials as a part of the bacteria’s survival and maintenance systems. One example of an 
efflux pump in E. coli involved in antibiotic resistance includes AcrAB-TolC efflux pump, 
whereas an example of a drug resistant pump in S. aureus is the norA system [33].   
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Inactivation of the antibiotic  
Bacteria may inactivate antibiotics by altering certain key groups through hydrolysing 
them or adding groups to them, rendering the antibiotic inactive. For example, some Gram-
negative species produce beta-lactamase, an enzyme that readily cleaves the C-N bond in 
beta-lactam antibiotics. An enzyme produced by bacteria called pencillinase specializes in the 
cleaving of the beta-lactam ring of Penicillin derived antibiotics. Such a strategy makes 
bacteria resistant to a specific type of antibiotic. E. coli expressing resistance to beta-lactam 
drugs are known as extended-spectrum beta-lactamase (ESBL) producing strains. The 
production of the beta-lactamase enzyme makes E. coli highly resistance to antibiotics and 
also very difficult to treat [31]. The prevalence of ESBL E. coli is a particular malice in 
urinary tract infections, leading to long term damage and even mortality [31]. Staphylococci 
may achieve the inactivation of antibiotics like streptogramins, antibiotics that by adding an 
acetyl group to the antibiotic [32].  
Modification of drug target 
A third strategy is the modification of the drug target within the bacterial cell, 
rendering the antibiotic ineffective due to its inability to attach to its target. Penicillin acts by 
linking to penicillin binding proteins (PBP) within the bacterial peptidoglycan cell wall, 
keeping the cell wall from forming properly. When bacteria such as Streptococcus 
pneumoniae gain resistance to penicillin, the PBPs are altered, making them unable to bind to 
penicillin. Another example of a target modification is the alterations of an rRNA necessary 
for the binding of a protein synthesis-inhibiting antibiotic within the ribosome. [32].  
Flavonoid effectivity on drug resistant bacteria 
Bacterial drug resistance is a constantly evolving landscape as selective pressures 
from the incorrect usage of current drugs in application continues to upregulate resistance to 
them. Flavonoid effectiveness on drug resistant bacteria has been studied with encouraging 
results. Flavonoids like galangin have shown to inhibit bacterial growth of resistant strains of 
S. aureus [4], and multiple studies report significant lowering of the MICs of known 
antibiotics, like amoxillin and ampicillin, against MRSA, due to a synergistic effect with 
Morin and Quercetin [6]. Also, studies have also shown effects of flavonoids like Acacetin-7-
O-neohesperidoside on ESBL E. coli in crude extracts [34]. Naringenin has also shown 
antimicrobial effects on MRSA S. aureus [2]. 
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Typically, the mechanistic strategy in place to attain potent antimicrobial protection is 
achieved by attacking several molecular targets in the bacterial cells. These strategies 
includes inactivating crucial enzymes or transport proteins in the cell membranes, 
inactivating the ability of bacteria to adhere to a surface to proliferate, and disruption of cell 
membranes. Disruption of cell membranes involves a mechanism leading to reduction in 
membrane fluidity [35]. 
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Susceptibility testing 
Minimum inhibitory concentration 
Susceptibility testing is employed to test susceptibly of known pathogens to known 
and quantified concentrations of treatment compounds. Susceptibility-tests are often reported 
as Minimum Inhibitory Concentrations (MICs), which is defined as the lowest concentrations 
of a drug that inhibits the visible growth of the organism. The MIC is used in order to 
ascertain and definitively categorize the susceptibility of a specific set of microbes to 
particular antimicrobial agents under defined conditions [36]. Empirically obtained values of 
MICs quantitatively (typically µg/mL) inform whether a bacterial strain is susceptible or not 
(treatable or non-treatable respectively) to a treatment compound, and are additionally used to 
delineate breakpoints that act as category boundaries for; susceptible (S), intermediate (I), 
resistant (R), sensitive-dose dependent (SD), or no interpretation (NI) [37]. Qualitative 
interpretation also typically accompanies MIC determination, and relies upon microbiological 
and clinical experience [36]. Derived concentrations of antimicrobial agents are subsequently 
utilized in order to successfully treat patients in clinical practice, with use of MICs also 
minimizing selection-risk for less susceptible bacterial isolates [37].  
Two common methods of evaluating MIC values are agar dilution and broth dilution 
[36]. Agar dilutions require a defined number of plated bacterial cells and known 
concentrations of antimicrobial agent added to the agar in various concentrations. Visual 
determination of growth on the plates after an incubation period (18-24hours) is required to 
determine if MIC values can be established or not.  
Broth dilution (using turbidimetry) 
Broth dilution involves inoculation of a volume of growth medium with a defined 
number of bacterial cells. Each individual volume can be treated with an increasing 
concentration of antimicrobial agent (protocol devised according to purpose of study) and 
after an incubation period the cell-density of each volume can be determined by use of a 
turbidity test where the optical density (OD) can be read and recorded with instruments. 
Dried wells can also be inspected for visible bacterial growth, the absence of which 
determines inhibition (Figure 8). Limitations of these tests however should be considered and 
it is accepted that in vitro testing such as the above is not equivalent to in vivo testing or 
efficacy of the treatment drug [38]. 
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Figure 8. Broth dilution assay for various antibiotics using 96 well plate   
Turbimetric kinetic method 
Defined volumes of culture medium with incremented concentrations of antimicrobial 
agent with known amount of inoculum added and held at a temperature conducive to bacterial 
growth conditions and simultaneously stirred. Aliquots can be extracted at temporal intervals 
with transmittance recorded as optical density recorded at each time interval when it is the 
turbimetric method. Transmittance correlates to bacterial concentration (CFU mL-1) [39]. 
Disk-diffusion 
Alternative methods for establishing MIC values are also utilized. The disk-diffusion 
method allows determination of compound sensitivity of a pathogen by placing an array of 
disks on an inoculated plate, each with a different compound. The differing compounds 
diffuse from the disks on to and outward on the plate surface and the diameter of any 
inhibited growth is measured and compared against standards in order to establish MIC 
values [37]. 
Spot-on method 
The spot-on method as employed in the experimental component of this report 
involves plating a known quantity of bacteria and spotting at demarcated locations varying 
concentrations of antimicrobial agents – either alone or in combination with another 
antimicrobial agent. The area of spotted antimicrobial agent will then inspected visually for 
inhibited growth after an incubation period [5]. 
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Hole plate method 
Similar to the spot-on method, except that holes (wells) are bored into the solidified 
agar and filled with the antimicrobial agent to be tested. Hole size can vary, however 5-6mm 
holes in diameter are commonly used. After an incubation period the diameter of the potential 
inhibition zone will be measured and recorded [40]. 
Epsilometers (Etests) 
Epsilometers or Etests are a relatively novel method of resolving MIC values [37] 
[36]. A strip impregnated with a quantified gradient of a known compound is placed on a 
plate that has been inoculated. The compound diffuses out from the strip and after incubation 
it is possible to visualize the concentration that inhibits growth by referencing the strip 
gradient. However there are limitations to this type of testing; the compounds available 
premade on strips are limited and set by the manufacturer and it is an expensive test for some 
purposes such as screening [36]. 
Alternative methods 
Additionally there are high-throughput automated methods for testing susceptibility. 
These systems although considered cost-effective, especially for large laboratories with a 
high volume of regular testing, also are not as of yet assured in terms of accuracy [36]. 
Combinatorial effects 
Justification for antimicrobial-combination therapy is generally attributed to a trifold 
reasoning; i) augmenting empiric coverage (verification of efficacy of at least one compound 
for a specific pathogen) ii) potentiating treatment-outcome based up the observed synergism 
yielded by two antimicrobial agents in vitro and iii) minimizing selection-based pathogenic 
acquired resistance [41]. For the purposes of this report, the impetus is predominately 
constituent ‘ii’, while of course bearing in mind the obvious advantage of minimizing 
selection-risk. While MIC is a quantitative measure of a microorganism’s sensitivity toward 
an antimicrobial agent (mono-therapeutic application), fractional inhibitory concentration 
(FIC) is the measure of the degree of synergism between two antimicrobial agents in a poly-
therapeutic application. Commonly, efficacy of combined antimicrobial agents is often 
assessed through the FIC which can be defined as a ratio of the MIC of a compound (A) 
administered in conjunction with another compound (B) to the observed MIC of said 
compound with singular administration [42].  
FICA = CA / MICA  and  FICB = CB / MICB 
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Where CA is the concentration of compound A used in combination and MICA is the 
minimum inhibitory concentration of A used alone. 
The FICI is a representation of the sum of FICs of each antimicrobial agent tested and 
it is based on the Loewe additivity zero-interaction theory.  
∑FIC = FICI = FICA + FICB 
The Loewe additivity zero-interaction theory is hypothetically forged in the reasoning 
that an antimicrobial agent will not interact with itself concluding that the effect of self-drug 
combination will only be additive resulting in a FICI of 1. A resulting FICI lower or higher 
than 1 will suggest synergy and antagonism respectively while an index of 1 suggests a 
neutral effect [42]. 
Bactericidal and bacteriostatic  
 Dependent upon infection type and/or clinic demands, drugs can be differentiated 
into bacteriostatic or bactericidal [37]. Bacteriostatic qualifies the concentration that inhibits 
growth and replication, whereas bactericidal qualifies the concentration required to kill the 
organism. To determine whether a compound and concentration are bactericidal, further 
testing is required. This concentration is termed Minimum Bactericidal Concentration 
(MBC). A small known volume of a treated and incubated sample can be plated on agar 
plates and further incubated. Potentially live bacterial cells are now placed under conditions 
that allow for growth which can be visually determined after an incubation period.  
A cell count of subsequently grown bacterial cells proffers the quantified MBC 
values. The concentration applied to the sample that yields a reduction of CFUs by 99.9% is 
generally accepted as the MBC. Typically for bactericidal compounds the MIC is concordant 
with the MBC, while for bacteriostatic compounds the MBC value is much higher than the 
MIC value [37]. 
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High Performance Liquid Chromatography 
Chromatography methods are based upon the principle of different molecules’ 
varying affinity to two phases: one stationary phase and one mobile phase. Each molecule in 
a mixture will have a different affinity to each of the two phases. When a mixture in the 
mobile phase flows over the stationary phase, molecules with high affinity to the stationary 
phase will stay in that phase longer and thus be held back, while molecules with high affinity 
to the mobile phase move along. This leads to separation of the different molecules in a 
mixture, and the retention time, that is the time it takes a molecule to pass the stationary 
phase, is detected. The retention time is characteristic for each molecule, which makes it 
possible to determine a mixture both qualitatively or quantitatively [43].  
HPLC is basically an improved form of column chromatography. Instead of letting a 
liquid phase drip though the column by gravity, it is forced though using high pressure up to 
400 atmospheres. This results in a much faster process, and also allows the packing material 
inside the column to have a much smaller particle size. The smaller the particle size, the 
greater surface area of the stationary phase, hence a greater interaction potential between the 
molecules and the stationary phase [44]. 
Normal and reverse phase HPLC  
There are two different types of HPLCs: The normal phase HPLC and the reversed 
phase HPLC. In the normal phase HPLC, silica particles are used with a non-polar solvent 
(hexane for instance). Polar molecules will stick longer to the polar silica particles and be 
held back longer than the non-polar molecules  
In reversed phase HPLC, long hydrocarbon chains are attached to the silica 
particles surface to make them non-polar, and a polar solvent is used (methanol for instance). 
Due to van der Walls forces the non-polar molecules in the mixture will interact with the 
hydrocarbon chains on the silica particles and be held back in the column. Contrary the polar 
molecules are more likely to stay in the mobile phase and move along [44]. 
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Summary of relevant flavonoid research 
Here we will summarize the research that has been done on the antibacterial effects of 
the compounds Quercetin, Morin and Naringenin on two bacterial species: the Gram-positive 
S. aureus and the Gram-negative E. coli. 
It is known that plants synthesize flavonoids in response to microbial infections, and 
many crude plant extracts, along with other flavonoid containing mixtures like propolis, have 
been found to have antimicrobial effects when tested in vitro [35] [2]. A broad range of 
flavonoids, both isolated and commercially available, has also been found to have 
antimicrobial effects in vitro [2]. 
Flavonoids tested individually 
Turbidimetric-kinetic method  
Different assays have been used to assess the MIC for different flavonoids against E. 
coli and S. aureus. In a study using the turbidimetric-kinetic method to test the MIC for 
Quercetin, Morin and Naringenin against E. coli ATCC 25922 and S. Aureus 25923 Alvarez 
et al. found Quercetin to be the most effective against S. aureus (MIC: 33.8 µg/mL) and 
Morin to be the most effective against E. coli (MIC: 57.2 µg/mL). Quercetin had an MIC of 
77.4 µg/mL against E. coli and Morin had an MIC of 160 µg/mL against S. aureus. The MIC 
of Naringenin was found to be 67.3 µg/mL against E. coli and 107 µg/mL against S. aureus 
[45]. In another study by Alvarez et al., using the same method and same bacterial strains, the 
MIC of Quercetin was found to be 34.4 µg/mL (S. aureus) and 77.7 µg/mL (E. coli), and the 
MIC for Morin was found to be 157.4 µg/mL (S. aureus) and 109.5 µg/mL (E. coli) [46]. The 
main difference between the findings of the two studies is the MIC of Morin, where there is a 
difference of 52.3 µg/mL between the two studies. 
Spot-on method, disk diffusion and similar methods 
Other studies have used the spot-on method, the disc diffusion assay or other similar 
methods. In a study using the spot-on method Lee et al. tested Quercetin and Naringenin on 
three different strains of bovine isolated MRSA, and found the MIC for Quercetin to be 10 
mM (~3 mg/mL) and for Naringenin 20 mM (~5.5 mg/mL) [5]. They also tested 7-O-butyl 
Naringenin and found it to have higher antibacterial activity than both Quercetin and 
Naringenin. Mandalari et al. conducted a study using the disc diffusion assay, where they 
found Naringenin to have an MIC of 800 µg/mL against E. coli K-12 MG1655, they did not 
find inhibition of S. aureus FI10139 up to 1000 µg/mL, which was the maximum 
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concentration tested [47]. Metwally et al. conducted a study using an agar diffusion assay, 
closely related to the disk diffusion assay, where they tested the antibacterial effect of 
Quercetin on one local isolate of E. coli and one of S. aureus, and found the MIC of 
Quercetin on both species to be 1.25 µg/mL [48].  
In a study done by Rauha et al. they used the hole-plate diffusion method, similar to 
the disc diffusion assay, to compare the antibacterial properties of Quercetin, Morin and 
Naringenin on S. aureus DSM 20231, and E. coli ATCC 8739 and ATCC 11775. 500 µl of 1 
mg/mL methanolic sample solution was pipetted into holes made in agar plates, and it was 
found that Naringenin and Morin had a strong antibacterial effect against S. aureus, and 
Quercetin had a clear antibacterial effect against the same. For E. coli there were slight 
response differences between the two strains. Morin and Quercetin were found to have no 
antibiotic effect against E. coli ATCC 8739, while Quercetin had a slight effect on the ATCC 
11775 strain (Morin was not tested on this strain). Naringenin had the strongest effect of the 
three against E. coli, with slight inhibition against ATCC 8739 and clear inhibition against 
ATCC 11775 [40].  
In a study conducted by Moon et al. they used both the disk diffusion assay and the 
broth dilution assay to test Quercetin and Naringenin against S. aureus KCCM 40510 
(MRSA), KCCM 12214, KCCM 11335, KCCM 32395. In the disk diffusion assay they 
found Quercetin to have a slight inhibition of all tested strains at 10 mM (~3 mg/mL) and a 
strong inhibition at 20 mM (~6 mg/mL), while Naringenin showed only slight inhibition of 
KCCM 12214 at 20 mM (~5.5 mg/mL) [49].  
Broth dilution method 
Using the broth dilution assay Moon et al. found the antimicrobial effect of 
Naringenin to be insignificant up to 140µM (~38 µg/mL), which was the maximum 
concentration tested. They found Quercetin to have a significant effect at 140 µM (~42 
µg/mL) [49]. Other experiments have used the broth dilution assay, using different names for 
the method. Woznicka et al. conducted a study using the dilution method to test Quercetin 
and Morin against E. coli ATCC 25922 and a clinical strain, and against S. aureus ATCC 
29213 (The same strain as we have used in our experiments) and a clinical strain. It was 
found that the Quercetin had a MIC of 62.5 µg/mL against all tested E. coli and S. aureus 
strains, while Morin had a MIC of 3,9 µg/mL against the two E. coli strains and 31,2 µg/mL 
against the two S. aureus strains [7].  
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Using microdilution in 96-well plate Gatto et al. tested the antibacterial effects of 
Quercetin on a clinical strain of E. coli and of S. aureus, and found no effect up to 100 
µg/mL, which was the maximum concentration tested [50]. Using a similar method Kang et 
al. found no antibacterial effect of 300 µM of either Quercetin (91 µg/mL) or Morin (82 
µg/mL), which were the maximum concentrations tested [51]. Tsuchiya et al. tested the 
antibacterial effect of Naringenin on 18 different strains of MRSA, using the dilution method, 
where they found the MIC of Naringenin to be in the range of 200-400 µg/mL [52]. 
Xu et al. used the dilution method to test the MIC for Quercetin against MRSA 
9247922, and found it to be 256 µg/mL [53]. Amin et al. conducted a study using the dilution 
method to test S. aureus ATCC 43300 and clinical strains of MRSA (n = 100), where the 
MIC for Quercetin was found to be 260 µg/mL against S. aureus ATCC 43300 and 
279±14.65 µg/mL for the clinical strains. Goyal et al. performed two-fold serial dilution to 
assess the MIC of Quercetin and Morin against E. coli MTCC-739 and S. aureus MTCC-740. 
It was found that Quercetin had an MIC of 32 µg/mL against S. aureus and 64 µg/mL against 
E. coli. The MIC for Morin was found to be 64 µg/mL against S. aureus and 128 µg/mL 
against E. coli [54]. Kopacz et al. tested the effect Morin on S. aureus (unspecified strain) 
and E. coli (unspecified strain) using the dilution method, and found that both E. coli and S. 
aureus were inhibited by 150 µg/mL of Morin, though this was the lowest concentration 
tested [55]. In a thesis by Belanger, the dilution assay was used to test the antibacterial effects 
of Morin against S. aureus ATCC 29213 (same strained used in this report) and E. coli ATCC 
25922, and here the MIC for Morin was found to be 1000 µg/mL for both species. 
Only one study, conducted by Tajuddeen et al., tested the compound 
Dihydrokaempferol. Using the dilution method they tested a clinical MRSA strain and a 
clinical S. aureus strain and found the MIC for Dihydrokaempferol to be 12.5 µg/mL against 
the MRSA strain and 6.25 µg/mL against the non-MRSA strain [28]. 
Combinatorial studies 
Several studies have also tested different combinations of Quercetin, Morin and 
Naringenin, and combinations of those with other flavonoids and antibiotics. 
Amin et al. conducted a study where they tested combinations of Quercetin, Morin 
and the flavonoid Rutin, and their combinatorial effects with a range of antibiotics, against S. 
Aureus ATCC 43300 and clinical strains of MRSA (n = 100). The MICs of amoxicillin 
(AMO), ampicillin (AMP), ceftriaxone (CET), cephradine (CEP, methicillin (ME) and 
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imipenem (IMP) were tested alone and combined with Morin and Rutin, Quercetin, or all 
three flavonoids. For both S. aureus and clinical MRSA strains (using the average MIC), 
combining antibiotics with Morin and Rutin reduced the MICs of the antibiotics by 60-75% 
(compared to using the antibiotics alone) except for AMP, which showed no reduction in 
MIC. Using Quercetin in combination with the antibiotics reduced the MICs of antibiotics by 
85-87.5%, except for AMO, which showed no reduction. When combined with both Morin, 
Rutin and Quercetin MICs for all antibiotics were reduced by 96-97%. The FICI for the 
different combinations were also calculated, and it was found that for antibiotics combined 
with Morin and Rutin (leaving out AMP) the range was 0.8-0.97. For antibiotics combined 
with Quercetin (leaving out AMO) the FICI was in the range of 0.66-0.83, and when 
combined with Morin, Rutin and Quercetin the FICI range was 0.31-0.68, the lowest being 
the combination with CET [6]. 
Alvarez et al. tested the combinatorial effects of Quercetin, Morin and Rutin, where 
they used the turbidimetric-kinetic method to test the effects of combining a varying 
concentration of one flavonoid (A) with a constant concentration of another flavonoid (B), on 
S. aureus ATCC 25923 and E. coli ATCC 25922, to find if a constant concentration of 
flavonoid B reduced the MIC of flavonoid A. Alvarez et al. used the following equation: µμ = µμ! − 𝑘! · 𝐶, (where µ: specific growth rate; µμ!: specific growth rate without drugs; ki: 
specific inhibition rate; C: concentration). Using the turbidimetric-kinetic data from the 
control, the flavonoid A-only test, and the flavonoid A+B combination, they calculate µT, ki 
and µ, respectively. They performed a linear regression and extrapolate to find the MIC for 
flavonoid A alone and for flavonoid A and B combined, for both E. coli and S. aureus. The 
MIC of Morin was reduced in the presence of Quercetin from 157.4 µg/mL to 37.9 µg/mL (S. 
aureus) and from 109.5 µg/mL to 27.4 µg/mL (E. coli). The MIC for Quercetin was reduced 
by the presence of Morin from 77.7 µg/mL to 25.0 µg/mL (E. coli), and in the presence of 
Rutin from 77.7 µg/mL to 44.6 µg/mL (E. coli). These combinations were considered 
synergistic by Alvarez et al., while other combinations showed little or no reduction of MICs. 
E. coli was generally considered more susceptible to synergism between flavonoids, 
proposedly because of flavonoid interactions with the structural membrane proteins porins 
[46]. 
Alvarez et al. used the same method in another study, examining other flavonoid 
combinations. It was found that the MIC of Kaempferol used alone was reduced by the 
presence of Quercetin from 84.3 µg/mL to 34.1 µg/mL (E. coli), and that the MIC of 
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Naringenin was reduced by the presence of Quercetin from 67.3 µg/mL to 29.5 µg/mL. Also 
in this study it was concluded that E. coli was more susceptible to combinations of flavonoids 
than S. aureus [45]. 
The two-fold broth dilution method was used by Goyal et al. to assess the MIC for 
Quercetin plus Morin on S. aureus MTCC-740 and E. coli MTCC-739. The MIC against E. 
coli was found to be 32 µg/mL, whereas it was found to be 16 µg/mL for S. aureus [54]. 
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Study Method E. coli Strain Q M N 
Alvarez et al. 2008 Turbidimetric-kinetic ATCC 25 922 77,4 57,2 67,3 
Alvarez et al. 2006 Turbidimetric-kinetic ATCC 25 922 77.7 109.5  
Belanger 2009 Broth dilution ATCC 25 922   1000   
Gatto et al. 2002 Broth dilution Clinical ≰100 ≰100   
Goyal et al. 2010 Broth dilution MTCC-739 64 128  
Kopacz et al. 2005 Broth dilution Unspecified  <150  
Mandalari et al. 2007 Paper disk diffusion K-12 MG1655    800 
Metwally et al. 2010 Agar diffusion Local isolate (clinical?) 1,25    
Woznicka et al. 2013 Broth dilution ATCC 25922 62,5 3,9   
Woznicka et al. 2013 Broth dilution Clinical 62.5 3.9  
Table 2. MICs of Quercetin (Q), Morin (M) and Naringenin (N) using various methods on E. coli strains. All values in 
µm/mL 
 
Study 
 
Method 
 
S. aureus Strain 
 
Q 
 
M 
 
D 
 
N 
Alvarez et al. 2008 Turbidimetric-kinetic ATCC 25 923 33,8 160  107 
Alvarez et al. 2006 Turbidimetric-kinetic ATCC 25 923 34.4 157.4   
Amin et al. 2015 Broth dilution ATCC 43300 260    
Amin et al. 2015 Broth dilution Clinical MRSA (n = 100) 279    
Belanger 2009 Broth dilution  ATCC 29213  1000   
Gatto et al. 2002 Broth dilution  Clinical isolate ≰100 ≰100   
Goyal et al. 2010 Broth dilution MTCC-740 32 64   
Kang et al. 2006 Broth dilution Newman (clinical strain) >91 >82   
Kopacz et al. 2005 Broth dilution Unspecified  <150   
Lee et al. 2013 Spot-on method MRSA 6, 7 & 8 3022   5445 
Mandalari et al. 2007 Paper disk diffusion FI10139    >1000 
Metwally et al. 2010 Agar diffusion  Local isolate 1,25    
Tajuddeen et al. 2014 Broth dilution Clinical MRSA   12,5  
Tajuddeen et al. 2014 Broth dilution Clinical S. aureus   6,25  
Tsuchiya et al. 1996 Broth dilution  MRSA (n = 18)    200-400 
Woznicka et al. 2013 Broth dilution  ATCC 29213 62,5 31,2   
Woznicka et al. 2013 Broth dilution  Clinical 62,5 31,2   
Xu et al. 2001 Broth dilution MRSA 9247922 256    
Table 3. MICs of Quercetin (Q), Morin (M), Dihydrokaempferol (D) and Naringenin (N) using various methods on S. 
aureus strains. All values in µg/mL  
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Materials and Methods 
Materials 
• Bacteria strains: S. aureus ATCC 29213 and E.coli ATCC 25922 
• Quercetin (CAS no. 117-39-5) 
• Naringenin (CAS no. 67604-48-2) 
• Morin (CAS no. 654055-01-3) 
• Dihydrokaempferol (CAS no. 104486-98-8) 
• Mueller Hinton Broth (MHB) 
• LB agar medium 
• Tetracycline (antibiotic) 
• Sterile Petri dish 
• Sterile 96-well polypropylenemicrotitre plates 
• Sterile Eppendorf tubes 
• Drigalski spatula, glass beads 
• Parafilm, plastic bags 
• Pipettes- 2-20µL, 10-100µL, 20-200µL, 100-1000µL 
• Sterile tips for pipettes 
• 96% Ethanol  
• 100% DMSO 
• 37°C incubator 
• Bunsen burner 
• Autoclave 
• Plate reader  
Quality assurance 
For all the experiments, each sample/dilution was repeated at least 2 times.  
In all assays, negative controls were used to assure the quality of conducted experiments.  
All the used compounds, solutions, apparatuses and machines can be traced back. A 
traceability table is placed in Appendix 1.   
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Bacteria isolation and CFU determination 
Streaking plates 
For both bacteria strains, the glycerol stocks from -80°C freezer were thawed and 
streaked on LB plates. Overnight incubation at 37°C, storage at 4°C. 
Overnight cultures 
Single colonies from streaked plates were used to inoculate the overnight (ON) 
cultures for all the experiments in 5mL MHB medium. ON incubation at 37°C, 180rpm.  
CFU determination 
In order to determine number in ON culture, serial dilution was performed according 
to Figure 9.  
 
Figure 9. 10-fold dilution scheme 
Dilution plating 
Dilutions with dilution factors 10-5, 10-6 and 10-7 were plated on LB agar plates 
according to Figure 10 for S. aureus and Figure 11 for E. coli. 
 
31/74 
 
 
Figure 10. Plating scheme for S. aureus 
 
Figure 11. Plating scheme for E.coli 
Cultures were distributed with Drigalski spatula (for S. aureus) or glass beads (for 
E.coli). Duplicates of each dilution were made. 
The plates were incubated ON at 37˚C, and single colonies of bacteria were counted. 
Following formula was used: 𝑁𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠   𝐶𝐹𝑈 ×𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛  𝑓𝑎𝑐𝑡𝑜𝑟𝑉𝑜𝑙𝑢𝑚𝑒  𝑝𝑙𝑎𝑡𝑒𝑑  (𝑚𝑙) = 𝐶𝐹𝑈/𝑚𝐿 
All the CFU counts from plated dilutions were used to calculate the average number 
of CFUs per 1mL of culture. This number was used as the ON bacteria concentration.  
For all of the calculation, see Appendix 2. For working environment and dangerous 
chemical labels, see Appendix 7.  
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Broth dilution assay 
Aim of the experiment  
The purpose of the experiment was to test the antibacterial efficiency of Quercetin 
and Dihydrokaempferol on S. aureus ATCC 29213, and to determine the MIC for these 
compounds. 
Procedure  
96-well plates were inoculated with ON culture diluted in MHB medium to 106 
CFU/mL. Dihydrokaempferol and Quercetin were serially diluted in 2% DMSO and MHB-
broth (Dihydrokaempferol starting from 450µL/mL, and Quercetin starting from 1,000 
µL/mL). Some wells were used as controls either containing bacteria with different dilutions 
of DMSO or tetracycline (antibiotic), or pure bacterial culture. The plates were incubated ON 
at 37°C, and the ODs were read by a plate reader. All samples were tested in duplicates. For 
calculations of compound concentrations and the plan for loading, see Appendix 3. Quercetin 
continued to precipitate in 4% DMSO and this assay was therefore not possible to continue.  
Spot-on test method 
Aim of the experiment  
The purpose of the experiment was to test the antibacterial efficiency of Naringenin, 
Morin and Quercetin on S. aureus ATCC 29213 and E.coli ATCC 25922 and to determine 
the MICs for these compounds. 
Procedure  
LB plates were inoculated with ON culture diluted in MHB medium to 106 CFU/mL 
and spread with Drigalski spatula (for S. aureus) or glass beads (for E.coli). Prepared 
dilutions of compounds were spotted in volumes of 10µL and air-dried. The ranges used for 
E. coli were 5 – 0.25 mg/mL for Quercetin, 10 to 1 mg/mL for Naringenin and 15 to 1 
mg/mL for Morin. The ranges used for S. aureus were 10 – 1 mg/mL for Quercetin, 10 to 1 
mg/mL for Naringenin and 10 to 1 mg/mL for Morin. A 100% DMSO negative control was 
also applied on each plate. The plates were incubated ON at 37°C. The MICs were defined as 
the lowest concentrations of compound at which the bacterial growth was completely 
inhibited. For the dilution plan, see Appendix 4 
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Combinatorial spot-on method 
Aim of the experiment  
For comparison with the MICs of the individual spot tests and for determination of 
potential synergism, antagonism or additive effects, the combinatorial antibacterial efficiency 
of Naringenin, Morin and Quercetin was tested using spot-on method.  
Procedure  
Combinatorial spot-on tests were performed on LB plates inoculated with 100µL or 
50µL of S. aureus ATCC 29213 (1.8×106 CFU/mL) or E. Coli ATCC 25922 (1.3×106 
CFU/mL) diluted in MHB medium and spread with glass beads. Stock solutions were made 
with 50% DMSO for both Naringenin and Morin, and with 70% DMSO for Quercetin due to 
precipitation. See Appendix 5 for dilution plan. 
Spotted final concentration ranges for combinatorial spot-on tests on E. coli were 
0.375-2.25 mg/mL for Quercetin, 1.125-6.75 mg/mL for Morin and 0.937-5.625 mg/mL for 
Naringenin, as shown in Table 4.  
Concentration of stock solution Final concentration in 10 µl spots 
Quercetin Naringenin Morin M/Q N/M N/Q 
4.5 11.25 13.5 6.75/2.25 5.625/6.75 5.625/2.25 
3.75 9.375 11.25 5.625/1.875 4.688/5.625 4.688/1.875 
3 7.5 9 4.5/1.5 3.75/4.5 3.75/1.5 
2.25 5.625 6.75 3.375/1.125 2.813/3.375 2.813/1.125 
1.5 3.75 4.5 2.25/0.75 1.875/2.25 1.875/0.75 
0.75 1.875 2.25 1.125/0.375 0.937/1.125 0.937/0.375 
Table 4. Concentrations of stock solutions and final concentrations spotted on the combinatorial plates for E. coli. All 
values are in mg/mL.  
For combinatorial spot-on tests on S. aureus, the spotted final concentrations range 
was between 0.25-1.5 mg/mL for Quercetin, 1.25-7.5 for Morin and 0.5-3 mg/mL for 
Naringenin, as shown in Table 5.  
Concentration of stock 
solution 
Final concentration in 10 µl spots 
Quercetin Naringenin Morin M/Q N/M N/Q 
3 6 15 7.5/1.5 3/7.5 3/1.5 
2.5 5 12.5 6.25/1.25 2.5/6.25 2.5/1.25 
2 4 10 5/1 2/5 2/1 
1.5 3 7.5 3.75/0.75 1.5/3.75 1.5/0.75 
1 2 5 2.5/0.5 1/2.5 1/0.5 
0.5 1 2.5 1.25/0.25 0.5/1.25 0.5/0.25 
Table 5. Concentrations of stock solutions and final concentrations spotted on the combinatorial plates for S. aureus. 
All values are in mg/mL. 
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10 µL of each combination shown in Table 4 (E. coli) and Table 5 (S. aureus) was 
spotted with a negative control of 100% DMSO for S. aureus and 70% or 50% DMSO for E. 
coli and air-dried. Each plate was divided into two parts: One with combinatorial spot-on 
tests, the other half with individual spot-on tests for one of the flavonoids used in the 
combination. This resulted in two plates for each combination. The plates were incubated ON 
at 37°C. 
Analysis of data  
Concentration ranges for each of the flavonoids, were determined based on calculated 
FICs (fractional inhibitory concentrations) for each flavonoid respectively. As previously 
mentioned, the FIC (fractional inhibitory concentrations) can be defined as a concentration’s 
ratio of the MIC. Recall that the FIC is calculated using the following formula:  
FICA = CA / MICA 
Combinations were then planned using the FICI, which is the sum of each flavonoid 
tested in combination, and were intended to combine the flavonoids in ratio 1:1. This was 
based on preliminary results of MICs, which were changed after the experiments (due to a 
repeated spot tests alongside the combination tests). The potency ratios have therefore 
changed from 1:1. The final FICs, FICIs and ratios are shown in Table 7.  
Spots with no visual growth were detected and were analysed using the Loewe 
additivity zero-interaction theory. The conclusion is always drawn from the lowest tested 
concentrations that show no visual growth. Recall that a FICI = 1 of a combination, has the 
same inhibitory effect as the MIC of one flavonoid tested individually, hence the effect would 
be additive. If the lowest FICI with no visual growth is > 1, the effect of the combination is 
corresponding to a higher concentration than the MIC of one flavonoid tested individually, 
which implies antagonism. Equally no visual growth at a FICI < 1 implies synergism, as it is 
corresponding to a lower concentration than the MIC of one flavonoid tested individually. 
HPLC test  
Aim of the experiment 
Due to the precipitation in the broth dilution assay, reverse phase HPLC tests were 
performed in order to determine the purity of chosen flavonoids: Naringenin, Morin and 
Quercetin.  
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Procedure 
Water and acetonitrile with 0.1% triflouraceticacid (starting with 90% water) was 
used as solvent and mobile phase. For solid phase a C18 resourcer column from GE 
Healthcare was used. Retention time was detected with UV-light wavelength 214 nm.  
For interpretation of raw data, a normalization procedure was done in order to 
determine the purity of the flavonoids, where area% for each flavonoid was calculated. Raw 
data used is shown in Table 14 in Appendix 6. Only peaks with similar retention time as the 
flavonoids were taken into account and the rest considered as noise. The graphs are shown in 
Appendix 6. 
Formula used to calculate the area%:  
𝑎𝑟𝑒𝑎% = 𝑎𝑟𝑒𝑎  𝑢𝑛𝑑𝑒𝑟  𝑓𝑙𝑎𝑣𝑜𝑛𝑜𝑖𝑑  𝑝𝑒𝑎𝑘Σ  𝑎𝑟𝑒𝑎  𝑢𝑛𝑑𝑒𝑟  𝑝𝑒𝑎𝑘𝑠   ×100% 
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Results 
Spot-on tests 
Minimum inhibitory concentration  
The spot-on method was used to determine MICs of Morin, Quercetin, Naringenin 
and Dihydrokaempferol on E. coli and S. aureus. For E. coli, the most potent flavonoid, with 
the highest MIC, was Quercetin (2 mg/mL), followed by Naringenin (3 mg/mL) and then 
Morin (4.5 mg/mL), whereas Dihydrokaempferol showed no inhibition (tested up to 5 
mg/mL). Comparatively, S. aureus showed less susceptibility to the tested flavonoids at 
similar concentrations, and though Quercetin had a similar MIC (2.5 mg/mL), Morin and 
Naringenin had significantly higher MICs (10 mg/mL) against S. aureus, see Table 6 for 
MICs and Figure 12, Figure 13, and Figure 14 for pictures of the spot tests. The MICs were 
determined based on results from the spot-on method and compared to replicates done in the 
combinatorial tests. The lowest MIC observed was chosen. The results show that Quercetin is 
the most potent flavonoid, as both bacterial species show highest susceptibility. As can be 
seen from the results, Quercetin is in the vicinity of 2.5 times more potent than Morin, for E. 
coli and 4 times more potent than Morin and Naringenin for S. aureus. Dihydrokaempferol 
showed no inhibition for the two bacterial species in the concentrations used for the spot-on 
method (used for E. coli).  
Table 6. Shows the minimum inhibitory concentrations (MICs in mg/mL) for chosen flavonoids against E.coli and S. 
aureus. The results are determined based on spot-on test method (Figure 12, Figure 13, and Figure 14) and from 
replicates done in combinatorial tests (Figure 15). All tests were performed with at least duplicates. All plates are 
showed in Appendix 4 and 5. 
 
 Morin Quercetin Naringenin Dihydrokaempferol 
E. coli 4.5 2 3 No inhibition 
S. aureus 10 2.5 10 No inhibition  
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Figure 12. Results from spot-on test method for flavonoids on E. coli. Left to right: Morin, Quercetin and Naringenin. 
(Only one plate from triplicates is shown, other plates are showed in Appendix 4).  
 
Figure 13. Results from spot-on test method for Dihydrokaempferol on E. coli. 
(Only one plate from duplicates is shown) 
 
Figure 14. Results from spot-on test method for flavonoids on S. aureus. Left to right: Morin, Quercetin and 
Naringenin. (Only one plate from triplicates is shown, other plates are showed in Appendix 4) 
 
Combinatorial effects 
For E. coli we saw strong synergism for all the flavonoid combinations, the most 
effective being Morin and Quercetin (FICI: 0.44), next being Naringenin and Quercetin 
(FICI: 0.5) and the least synergistic being Naringenin and Morin (FICI: 0.56). The ratios 
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(based on potency) for the three combinations were slightly different, as seen in Table 7. In 
some of the highest concentrations used in the combinatorial test for E. coli we did not see an 
inhibitory effect, which was seemingly due to precipitation of the flavonoids. 
For S. aureus the effect of combining the compounds were not as strong as for E. coli. 
Naringenin and Morin was the most effective combination against S. aureus and showed 
synergism (FICI: 0.7), Naringenin and Quercetin had a slightly synergistic effect (FICI: 0.9), 
and Morin and Quercetin showed slight antagonism (FICI: 1.125). The ratios for the three 
combinations were different, as seen in Table 7. 
E. coli 
M/Q    1.33:1 
S. aureus 
M/Q     1.25:1 
FIC_M FIC_Q FICI Effect FIC_M FIC_Q FICI Effect 
1.5 1.125 2.625 ppt. 0.75 0.6 1.35 ++ 
1.25 0.9375 2.1875 ppt. 0.625 0.5 1.125 ++ 
1 0.75 1.75 ++ 0.5 0.4 0.9 -- 
0.75 0.5625 1.3125 ++ 0.375 0.3 0.675 -- 
0.5 0.375 0.875 ++ 0.25 0.2 0.45 -- 
0.25 0.1875 0.4375 ++ 0.125 0.1 0.225 -- 
 
N/M    1.25:1 
 
N/M     0.4:1 
FIC_N FIC_M FICI Effect FIC_N FIC_M FICI Effect 
1.875 1.5 3.375 ppt. 0.3 0.75 1.05 ++ 
1.5625 1.25 2.8125 ++ 0.25 0.625 0.875 ++ 
1.25 1 2.25 ++ 0.2 0.5 0.7 ++ 
0.9375 0.75 1.6875 ++ 0.15 0.375 0.525 -- 
0.625 0.5 1.125 ++ 0.1 0.25 0.35 -- 
0.3125 0.25 0.5625 ++ 0.05 0.125 0.175 -- 
 
N/Q 1.67:1 
 
N/Q     1:2 
FIC_N FIC_Q FICI Effect FIC_N FIC_Q FICI Effect 
1.875 1.125 3 ppt. 0.3 0.6 0.9 ++ 
1.5625 0.9375 2.5 ++ 0.25 0.5 0.75 -- 
1.25 0.75 2 ++ 0.2 0.4 0.6 -- 
0.9375 0.5625 1.5 ++ 0.15 0.3 0.45 -- 
0.625 0.375 1 ++ 0.1 0.2 0.3 -- 
0.3125 0.1875 0.5 ++ 0.05 0.1 0.15 -- 
Table 7. The FIC values of each flavonoid in a combination and the FICI for each concentration against E. coli and S. 
aureus. Calculations of FICs for each compound and of FICI values have been done as described in a previous 
chapter. Ratios between the FICs for each compound in a combination are noted. The lowest concentration where 
visible growth of bacterial was inhibited is underlined. Refer to Table 4 (E. coli) and Table 5 (S. aureus) for the 
concentrations spotted on the plates. Refer to Figure 15 for effects on bacteria. 
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Figure 15. Spot test results for combinatorial effect of flavonoids on E. coli (left) and S. aureus (right). Top to bottom: 
Morin + Quercetin, Naringenin + Morin, and Naringenin + Quercetin. Top half of plates shows effect of 
combinations of flavonoids, whereas bottom half shows effect of individual flavonoids (Only one plate from 
quadruplicates is shown, see Appendix 5 for the rest). 
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HPLC tests 
Calculated purity-area% for Naringenin, Morin and Quercetin showed that Quercetin 
was the purest of the three flavonoids with 95.5%, followed by Morin with 90.2% and then 
Naringenin with 89.1%.  
 
  
41/74 
 
Discussion 
Comparative analysis of experimental data and current literature 
Precipitation of Quercetin and assay choice 
On a practical level, difficulty was experienced with dissolving Quercetin which lead 
to precipitation of the compound. It was suspected that the difficulties could be due to 
impurities in the compound, so HPLC testing was performed on Quercetin and it was found 
that the purity of the compound was 95.5%. It is therefore not certain that the difficulty faced 
in this report with dissolving Quercetin was due to the purity of the compound. HPLC purity-
testing was also performed on Naringenin (89.1%) and Morin (90.2%). Though precipitation 
was not an issue for these compounds, it cannot be ruled out that the purity influenced the 
results from the spot-on testing done in this report. Precipitation could be seen in initial 
attempts to experiment with the broth microdilution method and the spot-on test method, and 
could also be seen in the higher concentration spot-on tests with the combinatorial testing. A 
second attempt was made to dissolve Quercetin in higher concentration of DMSO so as to 
avoid precipitation, however even when dissolving stock in 4% DMSO, precipitation still 
formed in the well plate after 24 hour incubation in 37⁰C. The broth microdilution method 
was not attempted further and it was decided to perform testing only with the spot-on test 
method. Interestingly, results of the spot-on test method showed inhibition for combination 
testing with Quercetin in nearly all the concentrations above the determined MIC value, 
however inhibition was not seen at the highest concentrations where the compound slightly 
precipitates. This in itself strongly suggests that even slight precipitation of the compound 
can strongly attenuate inhibition efficacy and this may well have had an influence on our 
MIC determinations involving Quercetin. Cushnie and Lamb also state the potential for 
compounds to precipitate as a factor that needs to be considered when designing and 
assessing testing assays [2]. Another factor that may need to be considered is the use of 
dissolved stock compound and the possible degradation of quality over time. At least one 
study cited the importance of using freshly made stock solution with each round of testing 
[18] [56]. 
MIC of S. aureus and E. coli 
Using the spot-on test method we were able to determine MIC values for Quercetin, 
Naringenin and Morin against both S. aureus ATCC 29213 and E. coli ATCC 25922, 
however we were not able to establish MIC values for Dihydrokaempferol for either species 
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(using concentrations up to 7.5 mg/mL). The inability to determine MIC values and 
antimicrobial activity for Dihydrokaempferol seems to be consistent with current literature 
findings. However, in a study to determine activity against clinical MRSA and S. aureus, 
Tajuddeen et al. were able to determine MIC values for Dihydrokaempferol at 12.5 and 6.25 
µg/mL respectively [28]. This study however seems to be alone in its findings, especially 
given the determination of such low MIC values. We were unable to reproduce results that 
showed even minimal inhibition for Dihydrokaempferol even when spotting much higher 
concentrations up to 7.5 mg/mL. We were not able to see any inhibition of growth with the 
broth microdilution assay  (data for these tests not shown in results). This was the only study 
to have reported MIC values at such low concentrations and our experimental data do not 
support these findings. 
The MIC values we found for Quercetin for activity against E. coli and S. aureus were 
2 and 2.5 mg/mL respectively. Lee et al. were able to determine similar values for Quercetin 
against S. aureus with a value of 3 mg/mL by using the spot-on test method. Activity for 
Quercetin from other literature has been determined at typically much lower MIC values, 
although the methods used are predominately broth dilution methods (For MICs, refer to 
Table 2 for E. coli and Table 3 for S. aureus). 
Our experiments were also able to determine MIC values for Morin at 4.5 and 10 
mg/mL for E. coli and S. aureus respectively. The values we were able to determine 
experimentally are typically much higher than those found from our literature review. 
Belanger 2009 was able to determine a MIC value of 1 mg/mL for both E. coli and S. aureus, 
however these values were also established using the broth dilution method which may 
account for a 4.5 and 10 fold decrease in MIC values compared to those that we were able to 
determine experimentally. 
Determined MIC values for Naringenin on activity against E. coli and S. aureus were 
found at 3 and 10 mg/mL respectively. Review of current literature found several studies that 
were also able to determine MIC values of comparable value using the spot-on test method 
and similar methods for variant strains of S. aureus, however dissimilar methods again 
yielded much lower MIC values [5] [16]. MIC values for activity of Naringenin against E. 
coli comparable to those we determined in our lab work were not found from literature 
reviews. 
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Literature also yielded little data for MIC determination using the spot-on method as 
was used experimentally in this report. The validity of comparing quantified MIC values 
between methods also varies intuitively depending on the methods applied, and it would seem 
almost impossible to be able to draw concrete conclusions from comparative analysis where 
dissimilar methods are used. MIC values determined using the broth dilution as a general 
tendency are lower than those determined using the spot-on test method (for MIC values in 
literature, refer to Table 7). One possible reason for this may be that diffusion of the spotted 
compound may occur across the agar and create a concentration gradient across the spotted 
area. Close inspection of the plates showed that at least one of the spots above the MIC value 
showed this effect. 
However it may be more feasible to consider determined MICs between methods that 
are less dissimilar such as; disc diffusion, hole plate diffusion, agar diffusion technique and 
the spot-on test method that as a collective offer more insight into determined MIC values.  
Literature findings yielded little data for antimicrobial activity and MIC determination 
for Quercetin, Naringenin and Morin against the same strains of pathogens using the spot-on 
test method. However MIC determination from several studies performed on S. aureus 
indicate that MIC variation is not always that high between strains of the same species within 
the same study [52]. Additionally the validity of specificity of MIC determination for strain-
type may be further called into question as several review articles seem to omit specific 
strain-type in relation to MIC determination [2]. Amin et al. were also able to demonstrate 
the activity of Quercetin against 100 clinical isolates of MRSA to be 279.00±14.65 µg/ml, 
showing a variation of only 14.65 µg/ml. [6].  However, consideration of strain-type may still 
in some contexts need to be taken into account as some studies do show antimicrobial activity 
of some compounds against some strains but not others. Moon et al. found that Naringenin 
showed some activity against only one of the tested strains of S. aureus but not the other 
strains [49].  
It should not be overlooked that strain variation may be a starting point for expanding 
mechanistic understanding. Cushnie and Lamb highlights this point by discussing how their 
experimental data showed that the 4-quinolone-resistent S. aureus strain was susceptible to 
Galangin whereas other strains were not. The susceptible strain possesses a distinct amino 
acid sequence which subsequently went on to implicate specific enzymes relevant to the 
antimicrobial activity of Galangin for further study [2].  
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Variation in literature MIC values and possible causes 
Interesting to note is the variation that exists in determined MIC values when 
reviewing current literature. Cushnie and Lamb state that “widely conflicting” values can 
mostly be attributed to inter- and intra-assay discrepancies and methodology employed when 
performing susceptibility testing [2]. In a similar vein to that stated at the outset of this 
discussion regarding our experimental results, Cushnie and Lamb reinforce the importance of 
taking the operative mechanism of the testing method into consideration. A further 
consideration that needs to be noted even when using consistent methods is the variant 
diffusion-rates of compounds. This is particularly pertinent when considering methods that 
premise quantification upon diffusion like the disc diffusion method [57]. This factor may 
also be relevant with the spot-on method that was used in our experiment - particularly if the 
plates were not completely dried before spotting the compounds. This may allow the 
compound to diffuse to some degree into the surrounding hydrated inoculated substance 
causing a gradient of compound concentration to be established. Cushnie and Lamb 
additionally highlight the importance of controlling for the type and the volume of the agar. It 
was noted during our experiment that the depth of agar within the plating assay was not 
entirely consistent and when plating the inoculum the glass beads appeared on occasion to 
sink into the agar in some places and not in others. This then may have also influenced our 
determination of MIC values.  
In addition to factors with plated methods, broth volume, type and well size also need 
to be considered when using broth microdilution methods [2]. This factor however was not 
implicated in our report given that we only based our results upon the spot-on method due to 
precipitation complications with the broth microdilution method.  
According the National Committee for Clinical Laboratory Standards, the largest 
variable contributing to the integrity of results is the inoculum size [58]. According the 
review of antimicrobial activity performed by Cushnie and Lamb, many of the MIC values 
were derived from studies that neglected to either quantify the bacterial concentration and/or 
standardize the size of unenumerated inocula [2]. In our protocol for determining MIC 
values, we performed bacterial serial dilution and CFU determination in order to establish test 
bacterial suspension and also quantified the inoculum volume plated each time in order to 
control for this variable (see methods). The determination of bacterial concentration in ON 
culture determined for E.coli was 1.3 x 108 CFU/mL and 1.8 x 109 CFU/mL for S. aureus 
(refer to Appendix 2). Yet initially due to the difficulty we faced in plating bacteria correctly 
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in order to obtain countable (un-smeared) plates, we made an error in calculations resulting in 
using varying concentrations of inoculum for spot testing the two bacterial species. 
Specifically, 50 and 100 µL of 1.3 x 106 was plated for E. coli and 50 and 100 µL of 1.8 x 107 
was plated for S. aureus in the spot-on test for individual flavonoids. This discrepancy may 
have an influence on our results.  
Precipitation has already in this discussion been cited as a determining factor for 
validity of results. Salts formed by compounds have the ability to modulate contact between 
compound molecules and bacterial cells and precipitation can also be mistaken as bacterial 
cell growth leading to false-negative reports and misconstrued MIC values [2]. During the 
course of our experimentation, precipitation presented as an initial problem and contributed 
to the inability to test using the broth microdilution method with the 96-well plate. Consistent 
with the comments from Cushnie and Lamb regarding false-negative reporting, our 
experiments produced spots that were above the determined MIC value and yet presented as 
no inhibition at all. Either the precipitated salts give the impression of bacterial cell growth or 
the compound potency was diminished as to allow cell growth. This clearly reinforces 
statements by Cushnie and Lamb that false-negative reporting is a likely outcome when 
precipitation of compounds takes place.  
Combinatorial application  
We were able to show synergistic activity with all flavonoid combinations against E. 
coli. Mild synergism was seen for Naringenin plus Morin (FICI = 0.7) against S. aureus, 
while only slight synergism was seen for Naringenin plus Quercetin (FICI = 0.9) and slight 
antagonism was seen for Morin plus Quercetin (FICI = 1.125). The results for Naringenin 
plus Quercetin and Morin plus Quercetin are very close to additive, however further testing 
and adjustment of MICs for the flavonoids against S. aureus could affect these values. The 
results in this report for Naringenin plus Quercetin and Morin plus Quercetin on S. aureus are 
therefore considered to be additive, though further testing should be performed for both of the 
MICs of the flavonoids used in isolation and in these combinations, to elucidate the 
combinatorial effects of these specific combinations. All of the combinatory results for E. 
coli and the combination of Naringenin and Morin against S. aureus, show FICI values much 
lower and further from one than the aforementioned combinations and it is therefore less 
likely that these would be as affected by more rigorous testing and adjustment of MICs. The 
synergy between compound combinations was very strong for E. coli though, and given that 
the lowest concentrations tested showed inhibition, even lower concentrations should be 
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tested in order to further elucidate the MICs for these combinations and their corresponding 
FICI values. In this report the MIC concentrations for E. coli were all much lower (total 
flavonoid concentration: 1.3-2 mg/mL) than the ones for S. aureus (total flavonoid 
concentration: 4.5-7.5 mg/mL). This is partly due to the strong synergy observed for all 
flavonoid combinations, but also due to the MIC values for E. coli, which are much lower 
than those for S. aureus. Considering these differences in concentrations, possibly applying 
the antimicrobial effects of flavonoids in novel treatments seems even more promising 
against E. coli than S. aureus. 
The qualification of synergism/antagonism is derived from MIC values obtained for 
each of the compounds used in a singular application, and from their concentration in 
combination. As mentioned in the methods section, the combination tests were performed 
with a proposed 1:1 ratio of MIC of each compound. However the MIC values were re-
determined after the ratios for the combinatorial tests were performed so that the ratios were 
not equally weighted in terms of the FIC for each of the two compounds (For FIC values and 
ratios, refer to Table 7). This may have had an influence on the results of our combinatorial 
testing in terms of comparative analysis between the different combinations and further 
testing with a more complex assay involving varied FICs values from each compound may 
prove interesting.  
Synergism between drugs usually indicates that they have two different modes of 
antimicrobial action enhancing the antimicrobial effect, whereas antagonism can indicate two 
drugs competing for the same target which decreases the overall antimicrobial effect. 
Alvarez et al. performed two studies using the turbidimetric-kinetic method to test 
combinations of flavonoids and were able to show synergism between compounds [45] [8]. 
Alvarez et al. used Quercetin, Morin and Rutin in one study (2006) and Quercetin and 
Kaempferol, among others, in the other (2008). Both studies showed satisfactory 
bacteriostatic inhibition of E. coli. One study (2006) showed that the presence of Quercetin 
dramatically reduced the MIC for Morin against E. coli (from 157.4 µg/mL to 37.9 µg/mL), 
and that the MIC for Quercetin was reduced by the presence of Morin (from 77.7 µg/mL to 
25.0 µg/mL) and less so by the presence of Rutin (from 77.7 µg/mL to 44.6 µg/mL) against 
E. coli. In the other study by Alvarez et al. (2008) a constant concentration of Quercetin in 
conjunction with varying concentrations of Kaempferol was used, and here it was shown that 
the presence of Quercetin reduced the MIC of Kaempferol (from 84.3 µg/mL to 34.1 µg/mL). 
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The authors from their results concluded that Quercetin was the operative agent involved in 
increasing susceptibility of the E. coli bacterium in the combination test, based on the 
characteristic membrane structure of Gram-negative bacteria. The mechanistic action of 
Quercetin is postulated by the authors to target the porins located in the membrane of the 
Gram-negative bacteria. The porins which act as selective transmembrane channels, are 
known to retard the diffusion of larger molecules including traditional antibiotics into the 
periplasm of the bacterial cell. The channels possess charged amino acids which are situated 
on the interior of the channel that induce an electrostatic field which blocks the larger 
molecules. Alvarez et al. strongly suggest that Quercetin has the ability to neutralize this 
electrostatic field and therefore allow passage of bulkier antimicrobial compounds into the 
interior volume of the bacterial cell. As a way of reinforcing this supposition, results showing 
unsatisfactory inhibition on the Gram-positive S. aureus were seen. Given the relative 
observation of efficacies of the compounds on activity against E. coli and S. aureus, our 
combination test results would also be consistent with the findings from Alvarez 2008 and 
allow us to also conclude that Quercetin may be a useful and effective synergist when used in 
combination with other antimicrobial agents, including traditional antibiotics. In our 
experiments the combination of Morin and Naringenin also showed synergism on E. coli, but 
it was the combination showing the least amount of synergy, based on the FICI values. It 
could therefore also be relevant to perform further studies with Morin and Naringenin. 
Certainly this last supposition can be taken quite seriously for future consideration 
when noting the findings from studies by Muhammad et al. that clearly show drastic 
reduction of a wide range of antibiotic MIC values when using traditional antibiotics in 
combination with Quercetin, Morin and Rutin. Findings showed a wide range of antibiotics 
(only Ampicillin showed no reduction in MIC value) had their MIC values reduced by up to 
60-75% when used in combination with Morin and Rutin, and by up to 85-87.5% when used 
in combination with Quercetin (only Amoxicillin showed no reduction) [6].  
What is interesting to note in the study from Amin and colleagues is the relative 
consistency in reductions of antibiotic MIC value when using specific combinations with the 
flavonoids. Only a 15% range in difference between the newly reduced MIC values was seen 
across the different antibiotics used (see: Summary of relevant flavonoid research: 
Combinatorial studies) when used in conjunction with Morin and Rutin, and surprisingly only 
a 2.5% range in difference between the reduced MIC values when testing the antibiotics with 
Quercetin. Perhaps the most intriguing result is that all antibiotics had their MIC values 
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reduced by 96-97% when combined with all three flavonoids. The FICI values for the 
specific combinations of antibiotics and flavonoids also highlight the synergism, with a range 
of 0.8-0.97 seen for the combination with Morin and Rutin and 0.66-0.83 when combined 
with Quercetin and 0.31-0.68 when combined with all three. In Amin et al. the FICI ranges 
are evaluated using different cut-off values than in this report - where the cut-off values from 
Malatiadis et al. were followed. The FICI cut-off values used in Amin et al. are; synergistic 
(≤0.5), additive (>0.5 to 1), indifferent (>1 to <2) and antagonistic (≥2). The FICI values in 
Amin et al. were calculated using the same method as in this report, but due to the difference 
in cut-off values Amin et al.  only evaluate FICI values ≤0.5 as being synergistic. Therefore 
they conclude that only the combination of Quercetin, Morin and Rutin showed synergism. 
Following the cut-off values from Malatiadis et al. used in this report, the results from Amin 
et al. would possibly be argued to show synergism for Quercetin used with antibiotics, and 
slight synergism for Morin plus Rutin with antibiotics. The results from Amin et al. show that 
flavonoids can act synergistically with antibiotics, and that further research into combining 
flavonoids and antibiotics could prove useful in increasing potency of antibiotic treatment 
with flavonoids.  
Goyal et al. also performed a study testing the combination of Quercetin and Morin 
against both E. coli and S. aureus, using the broth dilution method. Here they found the MIC 
for the combination against E. coli to be 32 µg/mL and against S. aureus to be 16 µg/mL. FIC 
and FICI values were not calculated in this study, and for this reason it is not completely clear 
whether the observed inhibitory effects are synergistic, additive or antagonistic. The results 
from Goyal et al. establish an antimicrobial effect of the flavonoid combination for both 
bacterial strains, and this is in congruence with the results from this report, though our results 
relating to synergism of some combinations of flavonoids cannot be compared to the results 
of Goyal et al., due to the lack of FIC and FICI calculations in their study. 
Structure and antimicrobial activity 
While studies elucidating mechanistic underpinnings of flavonoid antimicrobial 
activity are quite limited, there have been some studies that seek to relate molecular structure 
to activity [2] [52]. Tsuchiya et al. were able to indicate that the 2’ and 4’ or 2’ and 6’ 
dihydroxylation of the B ring played an important role in the activity of flavanones against 
MRSA [52]. The importance of hydroxylation at the 2’ position for activity against several 
pathogenic species has also been highlighted by multiple other studies and Cushnie and Lamb 
strongly suggest this as an important structural component [59] [60]. 
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After preliminary testing with Dihydrokaempferol showed no activity, it was decided 
to choose an additional flavonoid to perform testing. Based upon the findings from Tsuchiya 
et al., Osawa et al. and Sato et al., we decided to choose Morin as a candidate to test for 
activity against E. coli and S. aureus given the hydroxylation on the 2’ carbon. However we 
were unable with our test results to show a tendency for Morin and the 2’ hydroxylation to 
show higher activity than Quercetin, which showed higher activity even though it lacks the 2’ 
component, (see results and flavonoids). 
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Conclusion 
In light of the increasing and problematic issue of pathogenic acquired resistance to 
traditional antibiotic treatments, this report sought to investigate the potential efficacy of 
novel treatments that could limit the usage of traditional antibiotics which strongly 
contributes to the prevalence of antibiotic resistance. Treatment with a combination of 
flavonoids from natural plant extracts may be able to manage infections and/or compliment 
use of traditional antibiotic treatment. 
Treatment potential of the flavonoids; Dihydrokaempferol, Quercetin, Morin and 
Naringenin against E. coli and S. aureus was investigated with the spot-on method, both 
individually and in combination. Antimicrobial activity was quantified through MIC values 
and FICI values were calculated for evaluating combinatorial effects between flavonoids.  
MIC values were determined for Quercetin, Morin Naringenin however this study was 
unable to determine an MIC value for Dihydrokaempferol (concentrations tested up until 7.5 
mg/mL) which is largely consistent with the findings from the literature review performed. 
The MIC values for Quercetin, Naringenin and Morin were determined to be 2, 4.5 and 3 
mg/mL respectively for E. coli and at 2.5, 10 and 10 mg/mL respectively against S. aureus. 
These MIC values were much higher than those typically determined in other studies, 
although some similar determinations were found in literature for Naringenin when similar 
methods were employed. Further testing of MIC values using more complex assays with 
broth dilution methods would be needed for a more accurate and thorough comparative 
analysis of MIC values. 
Combination testing found strong synergism between all three compounds against E. 
coli (FICI < 0.6) and only mild synergism was found for Naringenin and Morin against S. 
aureus (FICI = 0.7). Due to the strong synergism shown against E. coli, further testing of 
compounds against E. coli may determine lower MIC values and subsequently refine the FICI 
values of combination tests against E. coli. Review of current literature yields that Quercetin, 
Morin and Naringenin show synergistic effects when combined with other flavonoids or 
antibiotics for both E. coli and S. aureus. 
Our current test results posit encouraging indications that there may be potential for 
synergism between compounds and between compounds and traditional antibiotics against E. 
coli. Further testing using broth dilution testing combinations of flavonoids and antibiotics 
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would seemingly prove useful in allowing a more valid comparative analysis of MIC and 
FICI values for both flavonoids and combinations including those with antibiotics.  
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Glossary 
Agar 
Agar is a jelly like substance derived from the polysaccharide agarose, which forms the 
supporting structure in the cell walls of certain species of algae. 
Anterior nares 
The pair of anterior openings to the nasal cavity that allow the passage of air to the pharynx 
and ultimately the lungs during respiration.  
Antifungal  
Destroying fungi or inhibiting their growth. 
Antihyperglycemic 
Counteracting high levels of glucose in the blood, or an agent that so acts. 
Anti-inflammatory 
Property of a substance or treatment that reduces inflammation or swelling. 
Antioxidant  
A molecule that inhibits the oxidation of other molecules. 
Chemo-preventive 
A drug or compound that interferes with the process of cancer, able to inhibit, delay, or 
reverse carcinogenesis. 
Commensal microflora 
Micro-organisms which are present on body surfaces covered by epithelial cells and are 
exposed to the external environment (gastrointestinal and respiratory tract, vagina, skin, etc.). 
Diaminopimelic acid 
Diaminopimelic acid is an amino acid, representing an epsilon-carboxy derivative of lysine. 
Effectual 
Successful in producing a desired or intended result; effective. 
Empirical 
Relying on or derived from observation or experiment. Verifiable or provable by means of 
observation or experiment. 
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Flagella 
A lash-like appendage that protrudes from the cell body of certain prokaryotic and eukaryotic 
cells. The word flagellum in Latin means whip. The primary role of the flagellum is 
locomotion. 
Furunculosis 
Also called a boil; is a deep infection of the hair follicle; commonly caused by S. aureus; 
results in painful and swollen area on the skin and accumulation of pus and dead tissue 
Germination 
The process by which a plant grows from a seed. 
Horizontal gene transfer 
The transfer of genes between organisms in a manner other than traditional reproduction. 
Hydrolysing 
Cleavage of chemical bonds by the addition of water. 
In vivo 
Studies in which the effects of various biological entities are tested on whole, living 
organisms. 
Incubation 
To grow and maintain course of cell cultures. 
Inoculation 
To introduce a cell culture.  
Inoculum 
The cells, tissue, or viruses that are used to inoculate a new culture. 
Metabolites 
Any substance produced during metabolism. 
Neurodegenerative 
The progressive loss of structure or function of neurons, including death of neurons. 
Peptidoglycan 
A substance forming the cell walls of many bacteria, consisting of glycosaminoglycan chains 
interlinked with short peptides. 
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Phenylpropanoid metabolic pathway 
The biosynthetic pathway that metabolizes Phenylalanine into phenylpropanoids. 
Pili  
A hair-like appendage found on the surface of many bacteria. 
Porins 
Beta barrel proteins that cross a cellular membrane and act as a pore through which 
molecules can diffuse. 
Susceptibly 
The response of an organism to applied stresses. 
Transmittance 
The fraction of incident light that is transmitted through a sample, in contrast to the 
transmission coefficient. 
Upregulate 
An in increase in a biological response due to environmental or chemical signals.  
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Appendix 1 
Traceability 
Flavonoids 
Flavonoid CAS no. Batch no. Company 
Dihydrokaempferol 104486-98-8 BCBP2829V Sigma Aldrich 
Morin 654055-01-3 MKBR3718V Sigma Aldrich 
Naringenin 67604-48-2 04329KEV Sigma Aldrich 
Quercetin 117-39-5 SLBD8415V Sigma Aldrich 
Table 8. Compounds traceability table 
 
Equipment 
Name of apparatuses Identification no. Company 
Vortex 9346 Scientific Industries Inc. 
Eppendorf centrifuge C13IR Labuet International Inc.  
37°C incubator 8864845 B. Braun Biotech Int.  
Autoclave 3150 EV Tuttnauer 
Balance 1 25905735 Sartorius 
Balance 2 70504300  Sartorius 
Table 9. Equipment traceability table 
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Appendix 2 
Calculations for CFU determination 
Formula for calculation concentration in original culture:  𝑁𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠   𝐶𝐹𝑈 ×𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛  𝑓𝑎𝑐𝑡𝑜𝑟𝑉𝑜𝑙𝑢𝑚𝑒  𝑝𝑙𝑎𝑡𝑒𝑑  (𝑚𝑙)  
S. aureus culture concentration determination 
Amount plated, dilution factor, CFU count Bacterial concentration (CFU/ml) 
10 µl, 10-5, 198 CFU 198  ×10^50.01 = 1.98  ×10^9 
25 µl, 10-5, 325 CFU 325  ×10^50.025 = 1.3  ×10^9 
25 µl, 10-6, 17 CFU 17  ×10^60.025 = 6.8  ×10^8 
50 µl, 10-6, 71 CFU 71  ×10^60.05 = 1.42  ×10^9 
25 µl, 10-7, 6 CFU 6  ×10^70.025 = 2.4  ×10^9 
100 µl, 10-7, 18 CFU 18  ×10^70.1 = 1.8  ×10^9 
10 µl, 10-5, 153 CFU 153  ×10^50.01 = 1.53×10^9 
25 µl, 10-5, 422 CFU 422  ×10^50.025 = 1.69  ×10^9 
50 µl, 10-6, 116 CFU 116  ×10^60.05 = 2.32  ×10^9 
100 µl, 10-7, 19 CFU 19  ×10^70.1 = 1.9  ×10^9 
Average 1.8 x 109 CFU/ml 
 
E. coli culture concentration determination 
Amount plated, dilution factor, CFU count Bacterial concentration (CFU/ml) 
10 µl, 104, 1440 CFU 1440  ×10^40.01 = 1.4  ×10^8 
25 µl, 104 1431 CFU 1431  ×10^40.025 = 5.7  ×10^7 
25 µl, 105, 242 CFU 242  ×10^50.025 = 9.7  ×10^7 
10 µl, 106, 8 CFU 8  ×10^60.01 = 8  ×10^7 
25 µl, 106, 53 CFU 53  ×10^60.025 = 2.1  ×10^8 
10 µl, 107, 2 CFU 2×10^70.01 = 2  ×10^8 
25 µl, 107, 4 CFU 4×10^70.025 = 1.6  ×10^8 
Average 𝟏.𝟑 · 𝟏𝟎𝟖  𝑪𝑭𝑼/𝒎𝒍 
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Appendix 3 
Broth dilution Assay  
Pilot experiment: Desolving Quercetin  
Pilot experiment with dissolving Quercetin showed that it was precipitating at 
1,000µg/mL in 2% DMSO.  
Stock solutions  
For both Quercetin and Dihydrokeampferol stock solutions were made of 25mg/mL in 
100% DMSO. This was done by weighing out app. 0.025g of flavonoid and writing down the 
exact weight. To obtain the solution of exactly 25mg/mL, the weight is recalculated to get the 
volume of DMSO. Following proportion is used for this calculation: 
0.025g (to obtain 25mg/mL stock solution)   -   in 1mL DMSO 
eg. 0.0258 g (weight of flavonoid)                  - in x mL DMSO 
Flavonoids were carefully dissolved in calculated amount of DMSO and transferred to 
glass bottles. 
Also, because of precipitation of compounds in some concentrations of DMSO, it was 
decided to use also 50% and 70% DMSO as solvent. Moreover, due to same reason, some 
stocks solutions had lower concentration (5, 15 or 20 mg/mL). 
We decided to make a solution of 250 µg/mL of Quercetin (2% DMSO) instead, since 
that dissolves more completely. We still include the concentration of 1000 µg/mL and 500 
µg/ml, but we made this in 4% DMSO. We have a control for the 2% DMSO and for higher 
concentrations as well. 
Dilutions of flavonoids for experiments 
Quercetin 
Range of Quercetin used in experiment: 
15.6 µg/mL to 1000 µg/mL 
Calculating the concentration of the stock solution 
To calculate what the concentration of the stock solution has to be, to end up with a 
solution of 1000 µg/mL at 4% DMSO, we know that the concentration of the 1000 µg/mL 
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solution divided by the concentration of the stock solution should equals 0.04, meaning a 4% 
solution of DMSO: 
 
!"""  !!!"!!!!" = 0.04⇔ 25000 !!!" 
So we know that the stock solution should have a concentration of 25000 µg/ml 
 
Calculating the concentration of the Quercetin solution before mixing with bacteria 
We decided to mix bacteria and flavonoids in a 1:4 ratio (25 µl bacteria to 75 µl 
flavonoids), so we need to calculate what the concentration of the Quercetin solution should 
be: 
 1000 !"!" ∙ 100  µμ𝑙 = 𝑥 !"!" ∙ 75µμ𝑙⟺ 𝑥 = 1333.3   !"!" 
 
Calculating how much stock solution and MHB broth to mix to get Quercetin solution 
To make 2 ml of the flavonoid solution with a concentration of 1333.3µg/ml, we need 
to calculate the amount of stock solution to put in. The stock solution is 25000 µg/ml. 
 25000   !!!" ∙ 𝑥  µμ𝑙 = 1333.3   !!!" ∙ 2000µμ𝑙⇔ 𝑥 = 106.656µμ𝑙   
So we need to mix 106.66 µl of flavonoid stock solution with 1893.34 µl of MHB 
broth to get a solution with a concentration of 1333.3 µg/ml. 
 
Dihydrokaempferol 
Range of Dihydrokaempferol used in experiment: 
450 µg/mL– 4.06 µg/ml 
 
Calculating the concentration of the stock solution 
Since we are using a smaller concentration of Dihydrokaempferol than we do for 
Quercetin, it is very well dissolved in 2% DMSO. We know that the final concentration of 
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450 µg/mL divided by the stock solution concentration has to be equal to 0.02, to make the 
concentration of DMSO 2%. 
 
!"#!!!"!  !!!" = 0.02⇔ 𝑥 = 22500 !!!" 
 
Calculating the concentration of the Dihydrokaempferol solution before mixing with 
bacteria 
We calculate the concentration of the solution we are mixing in the 1:4 ratio with 
bacteria: 
 450 !!!" ∙ 100µμ𝑙 = 𝑥 !!!" ∙ 75µμ𝑙⇔ 𝑥 = 600 !!!" 
 
Amount of stock solution and MHB broth to mix to get Dihydrokaempferol solution 
To make the Dihydrokaempferol solution from the stock solution of 
Dihydrokaempferol, we need to calculate how much stock solution to mix with MHB broth: 
 22500 !!!" ∙ 𝑥  µμ𝑙 = 600 !!!" ∙ 2000  µμ𝑙⇔ 𝑥 = 53.3 !!!" 
Loading plan 
 
Quercetin 
Q no 
bacteria Dihydrokaempferol 
Tetra- 
cycline DMSO 
Only 
MHB 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1000 1000 1000 1000 450 450 450 2 10% 10% 10% 0 
B 750 750 750 750 300 300 300 2 8% 8% 8% 0 
C 500 500 500 500 150 150 150 1  6% 6% 6% 0 
D 250 250 250 250 75 75 75 1 4% 4% 4% 0 
E 125 125 125 125 32.5 32.5 32.5 0.5 2% 2% 2% 0 
F 62.5 62.5 62.5 62.5 16.25 16.25 16.25 0.5 1% 1% 1% 0 
G 31.3 31.3 31.3 31.3 8.13 8.13 8.13 B	   B	   B	   B	   0 
H 15.6 15.6 15.6 15.6 4.06 4.06 4.06 B	   B	   B	   B	   0 
Figure 16. Loading plan for 96-well plate experiment. All values are in µg/mL. B means bacteria in medium only. 
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Appendix 4 
Spot-on method tests of flavonoids individually 
Dilution plan for spot-on method against E. coli  
[25]Quercetin Naringenin Morin 
Conc. 
(mg/mL) 
stock sol 
5mg/mL 40µl 
DMSO Conc. 
(mg/mL) 
stock sol 
20mg/mL 40 µl  
DMSO Conc. 
(mg/mL) 
stock sol 
20mg/mL 40µl 
DMSO 
5 40 0 10 20 20 15 30 10 
3 24 16 6 12 28 10 20 20 
2.5 20 20 5 10 30 6 12 28 
2 16 24 3 6 34 5 10 30 
1.5 12 28 2.5 5 35 2.5 5 35 
1 8 32 2 4 36 2 4 36 
0.5 4 36 1.5 3 37 1.5 3 37 
0.25 2 38 1 2 38 1 2 38 
Table 10. E. coli spot test plan. 40 µL of stock was made for each flavonoid. Quercetin was made in 70% DMSO, 
Naringenin and Morin in 50% DMSO. 
Dilution plan for spot-on method against S. aureus  
Table 11. Plan for mixing solutions for spot testing of S. aureus 
  
Quercetin Naringenin Morin 
Conc. 
(mg/mL) 
ml of 
stock sol. 
ml of 
DMSO 
Conc. 
(mg/mL) 
ml of 
stock sol. 
ml of 
DMSO 
Conc. 
(mg/mL) 
ml of 
stock sol. 
ml of 
DMSO 
10 72 108 10 72 108 10 72 108 
6 43 137 6 43 137 6 43 137 
5 36 144 5 36 144 5 36 144 
3 22 158 3 22 158 3 22 158 
2.5 18 162 2.5 18 162 2.5 18 162 
2 14,4 165,6 2 14,4 165,6 2 14,4 165,6 
1.5 11 169 1.5 11 169 1.5 11 169 
1 7,2 172,8 1 7,2 172,8 1 7,2 172,8 
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Spot-on tests against E. coli  
 
Morin spotted on E. coli in concentration range 1-15 mg/mL with a negative control of 50% DMSO. 
 
Naringenin spotted on E. coli in concentration range 1-10 mg/mL with a negative control of 50% DMSO. 
 
Quercetin spotted on E. coli in concentration range 0.5-5 mg/mL with a negative control of 70% DMSO. 
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Spot-on tests against S. aureus  
 
Morin spotted on S. aureus in concentration range 1-10 mg/mL with a negative control of 100% DMSO. 
 
Naringenin spotted on S. aureus in concentration range 1-10 mg/mL with a negative control of 100% DMSO. 
 
Quercetin spotted on S. aureus in concentration range 1-10 mg/mL with a negative control of 100% DMSO. 
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Appendix 5 
Combinatorial spot-on tests 
Dilution plan for combinatorial spot-on method against E. coli  
Table 12. Dilution plan for combinatorial spot-on method against E. coli. All values are in mg/mL, unless stated 
otherwise. A volume of 180 µL was made for all combinations. 
 
Dilution plan for combinatorial spot-on method against S. aureus 
Table 13. Dilution plan for combinatorial spot-on method against S. aureus 
 
 
 
 
  
Quercetin Naringenin Morin 
Conc. 
(mg/mL) 
µL stock 
(15 mg/mL) 
70% 
DMSO 
(µl) 
Conc. 
(mg/mL) 
µL stock 
(15 
mg/mL) 
50% 
DMSO 
(µl) 
Conc. 
(mg/mL) 
µL stock 
(15 mg/mL) 
50% 
DMSO (µl) 
4.5 54 126 11.25 135 45 13.5 162 18 
3.75 45 135 9.375 112.5 67.5 11.25 135 45 
3 36 144 7.5 90 90 9 108 72 
2.25 27 153 5.625 67.5 112.5 6.75 81 99 
1.5 18 162 3.75 45 135 4.5 54 126 
0.75 9 171 1.875 22.5 157.5 2.25 27 153 
Quercetin Naringenin Morin 
Conc. 
(mg/mL) 
µL stock 
(15 mg/mL) 
70% 
DMSO 
(µl) 
Conc. 
(mg/mL) 
µL stock 
(15 
mg/mL) 
50% 
DMSO 
(µl) 
Conc. 
(mg/mL) 
µL stock 
(15 mg/mL) 
50% 
DMSO (µl) 
3 36 144 6 72 108 15 180 0 
2.5 30 150 5 60 120 12.5 150 30 
2 24 156 4 48 132 10 120 60 
1.5 18 162 3 36 144 7.5 90 90 
1 12 168 2 24 156 5 60 120 
0.5 6 174 1 12 168 2.5 30 150 
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Combinatorial spot-on tests against E. coli 
 
Combinatorial spot-on tests of Morin + Naringenin against E. coli. Both Morin and Naringenin are also spotted 
individually. The numbers written are not the final concentrations combined, but the concentrations of the stock 
solutions.  
 
Combinatorial spot-on tests of Morin + Quercetin against E. coli. Both Morin and Quercetin are also spotted 
individually. The numbers written are not the final concentrations combined, but the concentrations of the stock 
solutions. 
 
Combinatorial spot-on tests of Naringenin + Quercetin against E. coli. Both Naringenin and Quercetin are also 
spotted individually. The numbers written are not the final concentrations combined, but the concentrations of the 
stock solutions.  
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Combinatorial spot-on tests against S. aureus 
 
Combinatorial spot-on tests of Morin + Naringenin against S. aureus. Naringenin is also spotted individually. The 
numbers written are not the final concentrations combined, but the concentrations of the stock solutions.  
 
Combinatorial spot-on tests of Morin + Quercetin against S. aureus. Morin is also spotted individually. The numbers 
written are not the final concentrations combined, but the concentrations of the stock solutions.  
 
Combinatorial spot-on tests of Naringenin + Quercetin against S. aureus. Quercetin is also spotted individually. The 
numbers written are not the final concentrations combined, but the concentrations of the stock solutions.  
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Appendix 6 
HPLC tests  
Raw data 
Naringenin Morin	   Quercetin	  
Retention 
(ml) 
Area	  
(mAU*ml)	  
Height	  
(mAU)	  
Retention	  
(ml)	  
Area	  
(mAU*ml)	  
Height	  
(mAU)	  
Retention	  
(ml)	  
Area	  
(mAU*ml)	  
Height	  
(mAU)	  
165,4	   610,0495	   765,534	   16,27	   3,7957	   6,192	   21,81	   1,796	   3,474	  
180,69	   48,8807	   43,234	   21,11	   548,4175	   737,396	   24,45	   674,6871	   832,146	  
188,95	   143,0053	   212,657	   23,91	   7,0121	   7,838	   29,9	   14,6637	   16,211	  
191,45	   79,0142	   127,102	   25,01	   2,4383	   2,728	   30,52	   14,604	   15,806	  
205,04	   8664,4946	   4740,342	   29,05	   46,4035	   48,266	   33,57	   0,669	   0,694	  
235,79	   183,1813	   176,44	   	   	   	   	   	   	  
Sum:	   9728,6256	   	   	   608,0671	   	   	   706,4198	   	  
Table 14. Raw data from HPLC tests of Naringenin, Morin and Quercetin. Only peaks with similar retention time as 
the flavonoids are shown, as others were considered noise. Peaks of the flavonoids are highlighted, and the total area 
under the peaks is calculated for each flavonoid respectively. 
 
HPLC peaks 
 
Naringenin: Section of the UV-detected peaks for the HPLC test (wavelength 214nm). Y-axis is absorption (mAU) 
and x-axis is retention time (ml). Range of peaks taken into account: 165-236 ml.  
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Morin: Section of the UV-detected peaks for the HPLC test (wavelength 214nm). Y-axis is absorption (mAU) and x-
axis is retention time (ml). Range of peaks taken into account: 16-30 ml 
 
 
Quercetin: Section of the UV-detected peaks for the HPLC test (wavelength 214nm). Y-axis is absorption (mAU) and 
x-axis is retention time (ml). Range of peaks taken into account: 21-34 ml. 
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Appendix 7 
Safety 
All the actions involving handling bacteria culture is done next to ignited Bunsen 
burner and on earlier sterilized with 70% ethanol surfaces. All the samples, plates, solutions 
containing bacteria culture and which are supposed to be disposed, should be places in plastic 
waste bags meant for autoclavation.  
Preparation of samples and dilutions with DMSO should be conducted in the fume 
hood while using nitrile gloves. Special caution should be taken. Waste of undiluted 100% 
DMSO should be disposed in waste container marked with letter B.  
For nearly all laboratory actions, group members wear laboratory coats and gloves. Hands are 
sterilized with Alcogel.  
 
Labels for dangerous chemicals 
Substance Signal word, GHS Safety Waste group 
DMSO (100%) 
 WARNING GHS08 
Suspected of causing 
genetic effects 
Wear goggles;  
use nitril gloves;  
handle in fume cupboard 
B 
Ethanol (96%) 
 
DANGER 
GHS02 
Highly flammable liquid 
and vapour 
 
Keep away from fire/sparks; 
use gloves - 
 
 
